ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DCTA Directa Plus Plc

7.75
-0.30 (-3.73%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Directa Plus Plc LSE:DCTA London Ordinary Share GB00BSM98843 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.30 -3.73% 7.75 7.50 8.00 7.75 7.75 7.75 39,072 08:00:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Carbon And Graphite Products 10.86M -3.86M -0.0369 -2.10 8.41M
Directa Plus Plc is listed in the Carbon And Graphite Products sector of the London Stock Exchange with ticker DCTA. The last closing price for Directa Plus was 8.05p. Over the last year, Directa Plus shares have traded in a share price range of 7.75p to 28.00p.

Directa Plus currently has 104,418,755 shares in issue. The market capitalisation of Directa Plus is £8.41 million. Directa Plus has a price to earnings ratio (PE ratio) of -2.10.

Directa Plus Share Discussion Threads

Showing 251 to 272 of 575 messages
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
13/8/2020
10:45
Go and tell that to our 28% holder then, maybe he missed that during his due diligence? lol .. I know which opinion I follow. https://nantkwest.com/project/patrick-soon-shiong-2/In the early 1990's, Dr. Soon-Shiong pursued the science of stem cell and nanotechnology at NASA, performing experiments as part of the Shuttle program. Soon-Shiong's path to cancer research began while doing research for NASA that involved harnessing stem cells to make insulin. In 1991, he founded a biotechnology company to develop a novel nanoparticle anticancer drug with the concept of using "the tumors biology against itself".From 1997- 2010, Dr. Soon-Shiong served as Founder, Chairman and CEO of two global pharmaceutical companies: American Pharmaceutical Partners and Abraxis BioScience. In2008, Dr. Soon-Shiong sold American Pharmaceutical Partners (NASDAQ: APP) to Fresenius for approximately $4.6 billion and in 2010, sold Abraxis Bio Science to Celgene for approximately $3.8 billion.In January 2016, Dr. Soon-Shiong announced the formation of Cancer Breakthroughs 2020, a comprehensive collaboration of researchers, insurers, academic institutions and pharmaceutical companies that seeks to accelerate the potential of combination immunotherapy in the treatment of cancer. The initiative has a goal of initiating Phase 2 trials in 20,000 cancer patients within the next four years in addition to launching a revolutionary molecular diagnostic test. Known asGPS Cancer, the test enables analysis of the whole genome and target proteomics, transcending genomics to the era of clinic proteomics in cancer.Dr. Soon-Shiong currently serves as Chairman and CEO of NantWorks, an ecosystem of companies aiming to create transformative global health information and next-generation pharma development network. Under the NantWorks umbrella, Soon-Shiong also currently serves as Chairman and CEO of NantKwest (NK), a Nasdaq listed immunotherapy company focusing on Natural Killer cells, and Chairman and CEO of NantHealth (NH), a Nasdaq listed transformational healthcare company converging biomolecular medicine and bioinformatics with technology services to empower physicians, patients, payers, pharma and researchers to transcend the traditional barriers of today's healthcare system.Dr. Soon-Shiong is Chairman of the Chan Soon-Shiong Family Foundation and of the Chan Soon-Shiong Institute of Molecular Medicine, a non-profit medical research organization. He co-chairs the CEO Council for Health and Innovation at the Bipartisan Policy Center, is the Executive Director of the UCLA Wireless Health Institute and is a member of the Global Advisory Board of Bank of America. He also is an Adjunct Professor of Surgery at UCLA, a visiting Professor at the Imperial College of London, and a Professor of Microbiology, Immunology & Molecular Genetics and Professor of Bioengineering at the California NanoSystems Institute of UCLA. The Friends of the National Library of Medicine has honored him with their Distinguished Medical Science Award.In April 2016, Dr. Soon-Shiong received the Franklin Institute Award for his visionary leadership and commitment to advancing medical and scientific research and bringing new treatment options to cancer patients. Dr. Soon-Shiong was also honored at the Vatican in April 2016 and received the 2016 Pontifical Key Visionary Award. The award recognizes "medical innovators who change the course of history and reduce suffering on a global scale by blending visionary thinking with real action".
smackeraim
13/8/2020
10:23
Directa do not have ISO certification for their graphene product. Why not and should they be calling it graphene.The only graphene certified ISO product is made by Versarien.
packman8
13/8/2020
10:08
Oh and the worlds richest Dr holding 28% lol
smackeraim
13/8/2020
10:07
To be honest, masks great.. for me it's all about Asphalt and Italdesign :-)
smackeraim
13/8/2020
09:21
The only certification that matters to customers is ISO certification.
The Graphene Council verification is a paid for service that is not required by customers.

terry topper
13/8/2020
09:00
They don't look to be listed as a member co. of the graphene council? Take it that if they're not paying dues they won't get promoted?
bad gateway
13/8/2020
08:34
Not sure if there shall be large sales at prices quoted on website. Versarien masks half the price and fully certified. Also need to ask why G+ has not been certified by the graphene council.
packman8
13/8/2020
07:06
So what else can these anti viral / Cv19 properties come in useful for??
smackeraim
13/8/2020
06:28
These are turning themselves into the go to graphene co though.
Was impressed with their tarmac solution but getting this for the masks and having commercial negotiations started is as good if not better in todays world imo.

"These preliminary results confirm that the application of our technology can significantly enhance facemask efficacy and can help to reduce the spreading of SARS-CoV-2. Our G+® graphene solutions are non-toxic and environmentally sustainable, overcoming the health and other problems associated with current ion-metal or halogen treatments. The Company is now in early stage discussions with possible commercial partners for this application."

bad gateway
10/8/2020
13:08
While this is indeed great news it could well be a long lead time before the product is bought as a part of a sale out of Maranello.Someone buying 1m shares would perk it up also...
the white house
10/8/2020
13:05
Do you not like those red cars'
the white house
10/8/2020
13:00
The good news just keeps on coming yet share price barely moves.

What will it take for this to make real gains?

eggy toast
10/8/2020
06:37
Similar customer list to SCE :)
toffeeman
10/8/2020
06:35
"potential" customer list from the RNS..

"Maserati, Lamborghini, McLaren, Lotus, Aston Martin, Bentley, Rolls Royce, JLR and Porsche."

This has to be the most upmarket graphene stock on the planet.

bad gateway
09/8/2020
14:58
https://www.bbc.co.uk/news/av/world-europe-53628901/genoa-bridge-like-a-white-vessel-crossing-the-valley
smackeraim
06/8/2020
22:04
Ceo interview- https://youtu.be/zuWg9j0pRUU
smackeraim
31/7/2020
18:16
This was interesting, but does mention a competitor https://m.youtube.com/watch?v=dnE1nO6o-do
beergut
30/7/2020
19:20
DP for DMs
the white house
30/7/2020
10:11
Always worth another watch of Patrick talking about the zinc air batteries
itsyou
30/7/2020
09:05
Don't forget Patrick needs graphene for the work he is doing on zinc air batteries. And that would be a game changer for the whole world
beergut
30/7/2020
08:42
What price do you put on a company whose product could completely transform markets for asphalt, car paint, car parts, shoe soles, tyres for any vehicle and much more?.. I suspect the clever billionaire doctor knows!The Company's intellectual property portfolio which now comprises 56 patents in total: 33 granted and 23 pending, covering Directa Plus's production process and developed products and applications.
smackeraim
30/7/2020
08:33
Only a matter of time before the 28% holder swoops imo..From Wikipedia. His listed Nasdaq co Nantworks https://nantkwest.com/project/patrick-soon-shiong-2/NantWorks LLC founded in 2007[1] with headquarters in Culver City, California[2] is an American multinational conglomerate holding company. It owns a number of technology companies in the fields of healthcare, commerce, digital entertainment as well as a venture capital firm in the healthcare, education, science, and technology sectors. Particular technologies include machine vision, object and voice recognition, low power semiconductors, supercomputing, and networking technologies.[3]Chairman, CEO and founder is American Billionaire physician Patrick Soon-Shiong.[1]
smackeraim
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock